Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

301 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Host-directed therapies for antimicrobial resistant respiratory tract infections.
Maeurer M, Rao M, Zumla A. Maeurer M, et al. Curr Opin Pulm Med. 2016 May;22(3):203-11. doi: 10.1097/MCP.0000000000000271. Curr Opin Pulm Med. 2016. PMID: 26989822 Review.
New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.
O'Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, Zumla A. O'Grady J, et al. Among authors: maeurer m. Curr Opin Pulm Med. 2011 May;17(3):134-41. doi: 10.1097/MCP.0b013e3283452346. Curr Opin Pulm Med. 2011. PMID: 21415753 Review.
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNF╬▒ drugs.
Ferrara G, Murray M, Winthrop K, Centis R, Sotgiu G, Migliori GB, Maeurer M, Zumla A. Ferrara G, et al. Among authors: maeurer m. Curr Opin Pulm Med. 2012 May;18(3):233-40. doi: 10.1097/MCP.0b013e328351f9d6. Curr Opin Pulm Med. 2012. PMID: 22388583 Review.
Update on viral infections in lung transplantation.
Uhlin M, Mattsson J, Maeurer M. Uhlin M, et al. Among authors: maeurer m. Curr Opin Pulm Med. 2012 May;18(3):264-70. doi: 10.1097/MCP.0b013e3283521066. Curr Opin Pulm Med. 2012. PMID: 22388587 Review.
Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs.
Zumla A, Maeurer M. Zumla A, et al. Among authors: maeurer m. J Infect Dis. 2012 May 15;205 Suppl 2:S335-9. doi: 10.1093/infdis/jir881. Epub 2012 Mar 22. J Infect Dis. 2012. PMID: 22448017
Adjunct immunotherapies for tuberculosis.
Uhlin M, Andersson J, Zumla A, Maeurer M. Uhlin M, et al. Among authors: maeurer m. J Infect Dis. 2012 May 15;205 Suppl 2:S325-34. doi: 10.1093/infdis/jis197. Epub 2012 Mar 29. J Infect Dis. 2012. PMID: 22457298 Review.
Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections.
Ferrara G, Zumla A, Maeurer M. Ferrara G, et al. Among authors: maeurer m. Am J Med. 2012 Oct;125(10):1036.e1-8. doi: 10.1016/j.amjmed.2012.01.023. Epub 2012 May 16. Am J Med. 2012. PMID: 22608788 Review.
Drug-resistant tuberculosis: time for visionary political leadership.
Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A. Abubakar I, et al. Among authors: maeurer m. Lancet Infect Dis. 2013 Jun;13(6):529-39. doi: 10.1016/S1473-3099(13)70030-6. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531391 Review.
Rapid diagnostics urgently needed for killer infections.
Zumla A, Gant V, Bates M, Mwaba P, Maeurer M, Memish ZA. Zumla A, et al. Among authors: maeurer m. Lancet Respir Med. 2013 Jun;1(4):284-5. doi: 10.1016/S2213-2600(13)70099-7. Epub 2013 May 20. Lancet Respir Med. 2013. PMID: 24429144 Free PMC article. Review. No abstract available.
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial.
Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ. Skrahin A, et al. Lancet Respir Med. 2014 Feb;2(2):108-22. doi: 10.1016/S2213-2600(13)70234-0. Epub 2014 Jan 9. Lancet Respir Med. 2014. PMID: 24503266 Clinical Trial.
301 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback